Determination of biological studies and molecular docking calculations of isatin-thiosemicarbazone hybrid compounds

dc.authorid0000-0001-8710-2912tr
dc.contributor.authorKoçyiğit,Ümit M.
dc.contributor.authorDoğan, Murat
dc.contributor.authorMuğlu, Halit
dc.contributor.authorTaslimi, Parham
dc.contributor.authorTüzün,Burak
dc.contributor.authorYakan,Hasan
dc.contributor.authorBal, Halil
dc.contributor.authorGüzel,Emre
dc.contributor.authorGülçin,İlhami
dc.date.accessioned2023-06-21T13:30:00Z
dc.date.available2023-06-21T13:30:00Z
dc.date.issued2022/09/15tr
dc.departmentEczacılık Fakültesitr
dc.description.abstractDesign, synthesis, structural elucidation, and investigation of cytotoxic and antimicrobial activity, butyrylcholinesterase (BChE), and acetylcholinesterase (AChE) enzyme inhibition effects of isatinthiosemicarbazone hybrid compounds (1–15) are reported in this study. Hybrid compounds (14 and 15) were synthesized, isolated, and characterized for the first time. FT-IR, 1H NMR, and 13C NMR spectroscopic methods and elemental analysis were used to characterize the structures of the compounds. In the enzymatic evaluation, hybrid compound 13 was observed as the most potent inhibitor of AChE with a K˙ I value of 0.94 ± 0.13 μM (all compound K˙ I values between 0.94 ± 0.13 and 4.47 ± 0.92), also this compound was observed as the most potent inhibitor of BChE with a K˙ I value of 0.82 ± 0.11 μM (all compounds had K˙ I values between of 0.82 ± 0.11 and 3.48 ± 0.92). Almost all compounds were shown better inhibition profile than standard compound. In the theoretical calculations, the comparison of the biological activities of isatin-thiosemicarbazone hybrid derivatives against enzymes was studied. The enzymes studied in docking calculations are AChE and BChE. Then, ADME/T analysis was conducted to examine the drug properties of these derivatives. Besides, the antimicrobial activity of these molecules was investigated by the microdilution method according to Clinical Laboratory Standards Institute (CLSI) criteria in the study. Cytotoxic activity of isatin-thiosemicarbazone hybrids was determined by the XTT cell viability assay on human breast cancer cell lines MCF-7 and MDA-MB-231. Among the hybrid compounds, compound 8 exhibited the most potent cytotoxic activity with IC50 values of 23.42 ± 0.21 μg/mL and 19.68 ± 0.23 μg/mL on MCF-7 and MDA-MB-231 cell lines, respectively. Overall, the hybridization of isatin and thiosetr
dc.identifier.endpage133249tr
dc.identifier.issue133249tr
dc.identifier.scopus2-s2.0-85130091926en_US
dc.identifier.scopusqualityN/A
dc.identifier.startpage133249tr
dc.identifier.urihttps://hdl.handle.net/20.500.12418/13878
dc.identifier.volume1264tr
dc.identifier.wosWOS:000805641400011en_US
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherElseviertr
dc.relation.ispartofJournal of Molecular Structureen_US
dc.relation.publicationcategoryUlusal Hakemli Dergide Makale - Kurum Öğretim Elemanıtr
dc.rightsinfo:eu-repo/semantics/openAccesstr
dc.subjectThiosemicarbazone 5-methoxyisatin Enzyme inhibition activity Antimicrobial activity Molecular docking Cytotoxic activitytr
dc.titleDetermination of biological studies and molecular docking calculations of isatin-thiosemicarbazone hybrid compoundsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Abstracat.docx
Boyut:
12.81 KB
Biçim:
Microsoft Word XML
Açıklama:
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: